Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation.
Lee SH, Kim JM, Lee DG, Lee J, Park JG, Han TS, Cho HS, Cho YL, Bae KH, Park YJ, Lee SJ, Lee MS, Huh YM, Jo DY, Yun HJ, Jeon HJ, Kim N, Joo M, Kim JS, Lee HJ, Min JK.
Lee SH, et al. Among authors: lee sj, lee ms, lee j, lee dg, lee hj.
Cell Death Differ. 2021 Mar;28(3):968-984. doi: 10.1038/s41418-020-00628-4. Epub 2020 Sep 28.
Cell Death Differ. 2021.
PMID: 32989241
Free PMC article.